Clinical trials
Hyperlipoproteinemia Type II trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Vienna | 2 |
| National Medical Research Center for Rehabilitation and Balneology | 1 |
| Sang Hak Lee | 1 |
| SingHealth Polyclinics | 1 |
| The University of Western Australia | 1 |
| University of Cambridge | 1 |
| University of Nottingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 8 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus | 2 |
| Hypercholesterolemia | 2 |
| Atherosclerosis | 1 |
| Carotid Stenosis | 1 |
| Gout | 1 |
| Hyperbilirubinemia | 1 |
| Hypereosinophilic Syndrome | 1 |
| Hyperlipidemias | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.